TY - JOUR
T1 - Adeno-associated virus type 2 vectors
T2 - Transduction and long-term expression in cerebellar Purkinje cells in vivo is mediated by the fibroblast growth factor receptor 1: bFGFR-1 mediates AAV2 transduction of Purkinje cells
AU - Belur, Lalitha R.
AU - Kaemmerer, William F.
AU - McIvor, R. Scott
AU - Low, Walter C.
N1 - Funding Information:
This work was supported by Grant # P01 HD032652 from the National Institutes of Health.
PY - 2008/11
Y1 - 2008/11
N2 - The receptor for adeno-associated virus serotype 2 (AAV2) in Purkinje cells has not been identified, but based on work carried out in non-neuronal cell lines, heparan sulfate proteoglycan is thought to act as a primary receptor, with basic fibroblast growth factor receptor-1 being reported as a co-receptor. In this study, using antibody interference and protein competition strategies, we show specific reduction in Purkinje cell transduction by AAV2 vector in the presence of these inhibitors. We also demonstrate AAV2-mediated transgene expression in Purkinje cells in vivo that extends out to one year post-injection. These results provide new information on fibroblast growth factor receptor-1 involvement in AAV2-mediated transduction of Purkinje cells and have important implications for AAV-mediated treatment of various cerebellar disorders.
AB - The receptor for adeno-associated virus serotype 2 (AAV2) in Purkinje cells has not been identified, but based on work carried out in non-neuronal cell lines, heparan sulfate proteoglycan is thought to act as a primary receptor, with basic fibroblast growth factor receptor-1 being reported as a co-receptor. In this study, using antibody interference and protein competition strategies, we show specific reduction in Purkinje cell transduction by AAV2 vector in the presence of these inhibitors. We also demonstrate AAV2-mediated transgene expression in Purkinje cells in vivo that extends out to one year post-injection. These results provide new information on fibroblast growth factor receptor-1 involvement in AAV2-mediated transduction of Purkinje cells and have important implications for AAV-mediated treatment of various cerebellar disorders.
UR - http://www.scopus.com/inward/record.url?scp=55949122206&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=55949122206&partnerID=8YFLogxK
U2 - 10.1007/s00705-008-0222-7
DO - 10.1007/s00705-008-0222-7
M3 - Article
C2 - 18937030
AN - SCOPUS:55949122206
SN - 0304-8608
VL - 153
SP - 2107
EP - 2110
JO - Archives of Virology
JF - Archives of Virology
IS - 11
ER -